1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B22C1AC0EFEDDB6E8525845100627C5C
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-maximizing-impact-medical-affairs-product-launch-role-activities?opendocument
18
19opendocument
2035.170.78.142
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Launch Optimization

Maximizing the Impact of Medical Affairs in Product Launch: Role and Activities

ID: 5572


Features:

18 Info Graphics

15 Data Graphics

200+ Metrics

3 Narratives


Pages/Slides: 44


Published: 2019


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Maximizing the Impact of Medical Affairs in Product Launch: Role and Activities"

STUDY OVERVIEW
Medical Affairs has become one of the key players in new product launches. The function oversees vital activities that span the critical periods of pre-launch, launch and post-launch. In order to maximize its launch impact, Medical Affairs groups need to strategically deploy their resources and activities across key launch phases.

To clarify the emerging roles and activities that Medical Affairs is responsible for in a launch, Best Practices, LLC conducted a primary research study to examine the different parts that Medical Affairs plays in a product launch.

The first section of the study provides a qualitative overview on Medical Affairs and its growing role in launch; this chapter focuses on the development of a Medical Affairs strategy and work plan for guiding and supporting a product launch. Subsequent chapters examine the role and activities of Medical Affairs for launch. Specifically, these chapters look at the key launch activities that Medical Affairs leads vs. supports. Another chapter reviews how Medical Affairs collaborates with internal groups to align priorities and set the stage for a successful launch.

Medical Affairs leaders can use this study to compare how their organization utilizes Medical Affairs in the build-up to launch.

KEY TOPICS

  • Study Findings
  • Launch Strategy and Work Plan
  • Medical Affairs Role and Activity Effectiveness
  • Ensuring Cross-functional Alignment and Collaboration
  • Adapting to Ongoing Changes in MA Landscape
  • MA Leading vs. Supporting Launch Teams
  • Appendix

KEY METRICS

  • What is Medical Affairs role (lead vs. support) across these five activity areas?
  • How effective is your Medical Affairs organization in these five launch activities?
  • How does Medical Affairs collaborate with internal groups to ensure a successful launch?
  • What is Medical Affairs' role in cross-functional teams?
  • What tactics improve cross-functional collaboration and work alignment?
  • What is the change in Medical Affairs' launch role within the last three years - research and data generation
  • What is the change in Medical Affairs' launch role within the last three years - data dissemination and communication
  • What is the change in Medical Affairs' launch role within the last three years - education and organizational support
  • What is Medical Affairs' role in your cross-functional launch teams?
  • Does Medical Affairs play a leading/co-leading/support role in these different launch-related activities?
  • What are the major pitfalls encountered by Medical Affairs during launch?
  • What are the top 3 factors that facilitate Medical Affairs leadership?
  • What are the top 3 factors/reasons for Medical Affairs leading the launch team?
SAMPLE KEY FINDINGS
  • Improve launch team alignment by deploying work timelines and increasing strategy transparency 24 months before the launch.
    1. Jointly developing/sharing activity timelines with other launch teams, and clearly stating deadlines for handing materials over to other teams.
    2. Companies might be tight-lipped on critical strategic decisions to reduce information leaks to competitors. Twenty-four months before the launch, launch team should facilitate the culture of transparency and sharing with other teams.
METHODOLOGY

Best Practices, LLC engaged over 60 Medical Affairs leaders from 44 pharmaceutical, biotechnology and medical device companies in this research study through a benchmarking survey, interviews and a roundtable discussion.


Industries Profiled:
Pharmaceutical; Biopharmaceutical; Health Care; Biotech; Clinical Research; Laboratories; Medical Device; Chemical; Diagnostic


Companies Profiled:
Novartis; Clovis Oncology; Merck KGaA; Imbrium Therapeutics; AbbVie; Servier; Sanofi; Dermira; AstraZeneca; Exelixis ; Shire; Curis; Merck; Fidia; Boehringer Ingelheim; Medacta; Santen; EMD Serono; Takeda Pharmaceuticals; cipla; Daiichi Sankyo; Sandoz; Eisai; Vifor Pharma; Alcon; Bausch Health; GE Healthcare; Sanofi Genzyme; Alkermes; Lundbeck; Merz Pharma; Zydus; Torrent Pharmaceuticals Ltd.; Taiho Oncology; Alnylam Pharmaceuticals; Grifols; AcelRx; Vertex Pharmaceuticals; Gedeon Richter ; Celgene; Crescendo Bioscience; Orchard Therapeutics; GRAIL

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.